BMS-813160 |
| Catalog No.GC19077 |
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1286279-29-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
References:
[1]. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160 Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24.
Review for BMS-813160
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
Review for BMS-813160
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *